BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1229 related articles for article (PubMed ID: 26035864)

  • 1. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
    Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
    Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats.
    Martínez-Martínez E; Rodríguez C; Galán M; Miana M; Jurado-López R; Bartolomé MV; Luaces M; Islas F; Martínez-González J; López-Andrés N; Cachofeiro V
    J Mol Cell Cardiol; 2016 Mar; 92():96-104. PubMed ID: 26780438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fargesin improves lipid and glucose metabolism in 3T3-L1 adipocytes and high-fat diet-induced obese mice.
    Lee YS; Cha BY; Choi SS; Harada Y; Choi BK; Yonezawa T; Teruya T; Nagai K; Woo JT
    Biofactors; 2012; 38(4):300-8. PubMed ID: 22674784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocyte integrin-linked kinase plays a key role in the development of diet-induced adipose insulin resistance in male mice.
    Bugler-Lamb AR; Hasib A; Weng X; Hennayake CK; Lin C; McCrimmon RJ; Stimson RH; Ashford MLJ; Wasserman DH; Kang L
    Mol Metab; 2021 Jul; 49():101197. PubMed ID: 33647469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMO3 reprograms visceral adipocyte metabolism during obesity.
    Wagner G; Fenzl A; Lindroos-Christensen J; Einwallner E; Husa J; Witzeneder N; Rauscher S; Gröger M; Derdak S; Mohr T; Sutterlüty H; Klinglmüller F; Wolkerstorfer S; Fondi M; Hoermann G; Cao L; Wagner O; Kiefer FW; Esterbauer H; Bilban M
    J Mol Med (Berl); 2021 Aug; 99(8):1151-1171. PubMed ID: 34018016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
    Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
    Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lysyl oxidase (LOX) on corpus cavernous fibrosis caused by ischaemic priapism.
    Gao L; Wu C; Fu F; You X; Ma X; Qin F; Li T; Wang R; Yuan J
    J Cell Mol Med; 2018 Mar; 22(3):2018-2022. PubMed ID: 29278308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular lysyl oxidase: effect of a specific inhibitor on nuclear mass in proliferating cells.
    Saad FA; Torres M; Wang H; Graham L
    Biochem Biophys Res Commun; 2010 Jun; 396(4):944-9. PubMed ID: 20460108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.
    El Hajj EC; El Hajj MC; Ninh VK; Gardner JD
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H463-H473. PubMed ID: 29775412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice.
    Tsuchiya K; Sakai H; Suzuki N; Iwashima F; Yoshimoto T; Shichiri M; Hirata Y
    Endocrinology; 2007 Oct; 148(10):4548-56. PubMed ID: 17584959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice.
    Liu SB; Ikenaga N; Peng ZW; Sverdlov DY; Greenstein A; Smith V; Schuppan D; Popov Y
    FASEB J; 2016 Apr; 30(4):1599-609. PubMed ID: 26700732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet.
    Hwang JS; Park JW; Nam MS; Cho H; Han IO
    Metabolism; 2015 Mar; 64(3):368-79. PubMed ID: 25516476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial direct adipotropic actions of pitavastatin in vitro and their manifestations in obese mice.
    Ishihara Y; Ohmori K; Mizukawa M; Hasan AU; Noma T; Kohno M
    Atherosclerosis; 2010 Sep; 212(1):131-8. PubMed ID: 20466374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased aortic stiffness and attenuated lysyl oxidase activity in obesity.
    Chen JY; Tsai PJ; Tai HC; Tsai RL; Chang YT; Wang MC; Chiou YW; Yeh ML; Tang MJ; Lam CF; Shiesh SC; Li YH; Tsai WC; Chou CH; Lin LJ; Wu HL; Tsai YS
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):839-46. PubMed ID: 23413430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Kv1.3 channel blocker Vm24 enhances muscle glucose transporter 4 mobilization but does not reduce body-weight gain in diet-induced obese male rats.
    Jaimes-Hoy L; Gurrola GB; Cisneros M; Joseph-Bravo P; Possani LD; Charli JL
    Life Sci; 2017 Jul; 181():23-30. PubMed ID: 28549558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice.
    Lee YS; Cha BY; Choi SS; Choi BK; Yonezawa T; Teruya T; Nagai K; Woo JT
    J Nutr Biochem; 2013 Jan; 24(1):156-62. PubMed ID: 22898571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation.
    Granata R; Gallo D; Luque RM; Baragli A; Scarlatti F; Grande C; Gesmundo I; Córdoba-Chacón J; Bergandi L; Settanni F; Togliatto G; Volante M; Garetto S; Annunziata M; Chanclón B; Gargantini E; Rocchietto S; Matera L; Datta G; Morino M; Brizzi MF; Ong H; Camussi G; Castaño JP; Papotti M; Ghigo E
    FASEB J; 2012 Aug; 26(8):3393-411. PubMed ID: 22601779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues.
    Shin SS; Jung YS; Yoon KH; Choi S; Hong Y; Park D; Lee H; Seo BI; Lee HY; Yoon M
    J Ethnopharmacol; 2010 Jan; 127(1):47-54. PubMed ID: 19799979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
    Ohmura H; Yasukawa H; Minami T; Sugi Y; Oba T; Nagata T; Kyogoku S; Ohshima H; Aoki H; Imaizumi T
    Hypertens Res; 2012 Nov; 35(11):1063-8. PubMed ID: 22763477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.